The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/20621
StudyName: Eligibility Leukemia, Myeloid NCT00611247
Date of export from the portal: 02.07.2020
Date of Upload / last change: 07.03.2017
License: Creative Commons BY 4.0

----

Description: 
Phase 2 Study of Temozolomide to Treat Poor Risk / Refractory Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00611247
